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Summary
The human leukocyte antigen (HLA; known as MHC
in other vertebrates) plays a central role in the re-
cognition and presentation of antigens to the immune
system and represents the most polymorphic gene
cluster in the human genome [1]. Pathogen-driven
balancing selection (PDBS) has been previously hy-
pothesized to explain the remarkable polymorphism
in the HLA complex, but there is, as yet, no direct sup-
port for this hypothesis [2, 3]. A straightforward pre-
diction coming out of the PDBS hypothesis is that
populations from areas with high pathogen diversity
should have increased HLA diversity in relation to
their average genomic diversity. We tested this pre-
diction by using HLA class I genetic diversity from
61 human populations. Our results show that human
colonization history explains a substantial proportion
of HLA genetic diversity worldwide. However, be-
tween-population variation at the HLA class I genes
is also positively correlated with local pathogen rich-*Correspondence: prugnolle@yahoo.frness (notably for the HLA B gene), thus providing
support for the PDBS hypothesis. The proportion of
variations explained by pathogen richness is higher
for the HLA B gene than for the HLA A and HLA C
genes. This is in good agreement with both previous
immunological and genetic data suggesting that HLA
B could be under a higher selective pressure from pa-
thogens.
Results and Discussion
There are several lines of evidence suggesting that ge-
netic diversity at the HLA (MHC) complex is driven and
maintained by a process of diversifying selection [4–10]:
(1) A large number of alleles have been observed in
nearly all vertebrates studied to date [11], even in spe-
cies with virtually no genetic diversity at other loci [8];
(2) alleles are distributed more or less evenly within
populations [7]; and (3) the rate of nonsynonymous
substitutions in the antigen binding region of the mole-
cule is higher than that of synonymous substitutions
[4, 5].
The mechanisms that have been proposed to explain
the evolution of HLA (MHC) polymorphism in natural
populations vary from MHC-dependent mate selection
and preferential abortion to various pathogen-driven
selection pressures (see [2] for an extensive review).
Pathogen-driven selection is expected to operate when
specific alleles are favored because of their ability to
provide protection from different pathogen species or
strains. There is much evidence, both from immunology
and genetics, that points toward pathogen-driven se-
lection for HLA diversity. For example, several studies
report that specific HLA (MHC) alleles provide in-
creased resistance against single pathogens [12–17].
Moreover, more diverse individuals at this gene com-
plex tend to have higher fitness when challenged with
a variety of pathogens, suggesting the presence of bal-
ancing selection (i.e., heterozygotes have higher fitness
than either homozygote genotype) [18–23]. However,
although all these elements are compatible with PDBS
[2, 18, 24], none of these findings is really sufficient to
conclude that extreme polymorphism of HLA (MHC)
genes in natural populations is driven by the diversity
of pathogens encountered [3, 16, 25, 26].
A testable prediction from the PDBS hypothesis is
that human populations from areas with high pathogen
diversity should have increased HLA diversity in rela-
tion to their neutral diversity. This is because individuals
with higher variability at the HLA genes are predicted
to cope with a higher number of pathogens. In this pa-
per, we test this prediction with three different sources
of information: (1) the genetic diversity at HLA class I
genes (A, B, and C) from 61 human populations distrib-
uted over the world (see the Supplemental Data avail-
able with this article online for more details on methods
and populations); (2) estimates of intracellular patho-
gen richness (the total number of intracellular human
disease agents known from each country where HLA-
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1023typed populations originate (see Supplemental Data);
and (3) the geographic distance of each population
from East Africa along likely ancient colonization routes
(see Supplemental Data; Figure 1), to control for the
effect of past colonization history.
The diversity of a gene under selection in any popula-
tion is not only a function of selective factors acting
specifically on that locus, but also of demography that
similarly affects all loci in the genome [27]. We have
recently shown that the genetic diversity observed in
current human populations at neutral markers (HSn) is
extraordinarily well correlated with the geographic dis-
tance through landmasses between those populations
and East Africa (r2 = 85%) [28]. Here, we further improve
on this correlation (r2 = 87%) by applying the following
transformation to neutral genetic diversity: HSn* = Log
[HSn/(1−HSn)]. Such a strong relationship allows us to
use geographic coordinates as proxies for the neutral
genetic diversity of populations situated at any point
on the globe. Such information can be further exploited
to disentangle the effect of past colonization history
and potential natural selection that may have shaped
the current apportionment of genetic diversity at any
locus in the genome.
Worldwide variation in HLA diversity (HSHLA*) is signif-
icantly correlated to geographic distance from East
Africa (the distance being computed through land-
masses), with populations farther from Ethiopia being
characterized by lower genetic variability (Table 1; Fig-
ure 2). Geographic distance and, hence, human coloni-
zation history explains only between 17% to 39% of the
genetic diversity observed at HLA genes (Table 1; Fig-
ure 2). Although sampling effects could be invoked to
explain why the correlation observed for HLA genes is
lower than the one previously obtained with 377 neutral
microsatellite markers [28], selective pressures im-
posed by pathogens also seem important. Indeed, the
remaining proportion of HLA diversity, which is not ex-Figure 1. Shortest Routes (in Purple) through Landmasses and Specified Land Bridges between the 61 Populations Analyzed (Red Dots) and
a Hypothetical East African Origin
Geographic distances have been computed as paths connecting vertices (in green) on land with an algorithm based on graph theory (see [28]).those exposed to fewer pathogens (Table 1). The corre-
Table 1. Regression Analyses for the Relationship among HLA
Genetic Diversity (HSHLA*), Geographic Distance from Africa (Dist.
Africa), and Intracellular Pathogen Species Richness
HLA A HLA B HLA C
n 61 59 48
Model I
Dist. Africa r2 39%*** 17%*** 35%***
Path. Rich. r2 5%* 10.5%** 2.6% ns
Model II
Dist. Africa r2 39%*** 17%*** 35%***
Viruses r2 8%** 11%** 4.7% ns
Model III
Dist. Africa r2 39%*** 17%*** 35%***
Bacteria O r2 1.5% ns 4% ns 2% ns
Model IV
Dist. Africa r2 39%*** 17%*** 35%***
Bacteria F r2 0.2% ns 6%* 0% ns
Model V
Dist. Africa r2 39%*** 17%*** 35%***
Protozoa r2 4%* 6%* 0.5% ns
Regression models I–V were fitted independently according to the
procedure detailed in Statistical Analyses (see Supplemental Data).
Path. Rich, Bacteria O, and Bacteria F denote species richness of
all intracellular pathogens and obligate and facultative intracellular
bacteria, respectively. n represents the number of populations
genotyped, and r2 the proportion of variance explained by each
independent variable. All the slopes of regressions between
pathogen richness and HLA class I diversity were positive. P values
for F tests: *** < 0.001; ** < 0.01; * < 0.05; ns, non-significant.plained by the human colonization history, is signifi-
cantly correlated with pathogen richness (Table 1). Hu-
man populations that are exposed to a more diverse
array of pathogens show higher HLA diversity than
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1024Figure 2. Partial Residuals of HSHLA* against Distance from Africa and Virus Richness, the Two Predictors from Our Model
(A–C) Partial residuals of HSHLA* (after fitting Virus Richness) versus the Distance from Africa (in km) for HLA A (A), HLA B (B), and HLA C
(C) genes.
(A#–C#) Partial residuals of HSHLA* (after fitting Distance from Africa) versus Virus Richness for HLA A (A#), HLA B (B#), and HLA C (C#) genes.
More details about these regressions are given in Table 1 (Model II) for all HLA class I genes. Lines represent partial linear regressions. The
size of the points is proportional to the weights applied to HSHLA* in the model. The different colors correspond to the different ethnic groups
(dark blue, African populations; sky blue, Middle East populations; orange, European populations; green, East Asian populations; brown,
Oceanian populations; and purple, American populations).lation is significant for HLA A and B genes. This rela- p
ationship is mainly driven by virus richness (Table 1),
which explains a higher proportion of the remaining t
ovariations for HLA B (11%) than for HLA A (8%) and
HLA C (4.7%). Several lines of evidence reveal these a
cresults to be very robust. First, we obtain similar pro-ortions when we reanalyze the HLA A and B datasets
fter subsetting them to include only the populations
hat are available for HLA C (n = 48; see Table S2). Sec-
nd, alternative geographic models (including latitude
s another potential explanatory variable) do not
hange the results qualitatively either (Table 2). Finally,
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1025Table 2. Regressions for the Internal Controls and the Alternative
Geographic Model (see Statistical Analyses)
Internal Controls
HLA DRB1 Dist. Africa r2 47% (−)***
Viruses r2 4% (−) ns
Locus ms D12S1638 Dist. Africa r2 57% (−)***
Viruses r2 0.2% (−) ns
Locus ms D20S103 Dist. Africa r2 31% (−)***
Viruses r2 <0.1% (−) ns
Locus ms D10S1412 Dist. Africa r2 67% (−)***
Viruses r2 1.3% (−) ns
Locus ms D16S3396 Dist. Africa r2 22% (−)***
Viruses r2 0.3% (+) ns
Locus ms D4S3243 Dist. Africa r2 14% (−)**
Viruses r2 2.8% (−) ns
Locus ms NA-D6S-1 Dist. Africa r2 16% (−)**
Viruses r2 1.6% (−) ns
Locus ms D6S1009 Dist. Africa r2 16% (−)**
Viruses r2 0.6% (−) ns
Locus ms D5S2501 Dist. Africa r2 40% (−)***
Viruses r2 5% (+) ns
Locus ms D10S1430 Dist. Africa r2 17% (−)**
Viruses r2 0.2% (+) ns
Locus ms D21S1437 Dist. Africa r2 16% (−)**
Viruses r2 0.7% (+) ns
Alternative Geographic Model
HLA A Dist. Africa r2 39% (−)***
Abs. Lat. r2 5% (−)*
Viruses r2 7% (−)**
HLA B Dist. Africa r2 17% (−)***
Abs. Lat. r2 <0.1% (+) ns
Viruses r2 11% (+)**
HLA C Dist. Africa r2 35% (−)***
Abs. Lat. r2 <0.1% (+) ns
Viruses r2 4.7% (−) ns
Internal Controls: Regressions between genetic diversity at one
HLA locus of class II (HLA DRB1) and at ten microsatellite markers
(ms) randomly chosen from the 377 used in Rosenberg et al. [35],
geographic distance from Africa (Dist. Africa), and virus species
richness. Alternative Geographic Model: The absolute value of the
latitude (Abs. Lat.) of the countries from which populations come is
entered as another potential explanatory variable of the HLA class I
genetic diversity. r2 represents the proportion of variance explained
by each independent variable. (−) or (+) indicates the sign of the
regression slope. P values for F tests: *** < 0.001; ** < 0.01; * < 0.05;
ns, non-significant.as we expected, when the same tests are performed
for genes that are not expected to be under the selec-
tion of intracellular pathogens (one locus of HLA class
II and ten randomly selected microsatellite markers), no
significant relationship was ever found with virus rich-
ness (Table 2).
Our results therefore support the PDBS hypothesis
and further suggest that pathogens (notably viruses)
might exert a stronger selection pressure on the HLA B
gene than on HLA A and HLA C genes. These conclu-
sions are supported by previous studies. First, it has
been demonstrated that the strongest balancing selec-
tion operates at the HLA B locus (selection coefficient
s = 4.2%; [29]) followed by the HLA A (s =1.5%; [29])
and HLA C loci (s = 0.26%; [29]; see also [30]), which
is in good agreement with the proportion of variance
explained by pathogen richness for the different HLA
class I genes in the present study (Table 1). Second, it
has been shown that, despite apparently similar rolesin pathogen defense (notably against viruses), there are
well-established differences between HLA class I loci
[10]. HLA C alleles are expressed at lower levels on the
cell surface than HLA A and HLA B [31], and, thus, it is
not unexpected that HLA C diversity is the least driven
by pathogen selection of the three HLA class I loci. For
the difference in selection between HLA A and B, it has
been very recently demonstrated that the HLA B gene
could play a larger role in the successful containment
of viral infection (notably HIV infection) and would
therefore be under higher diversifying selection pres-
sure from the intracellular disease agents (notably
viruses) than the HLA A gene [32]. Finally, many studies
report that some specific HLA (MHC) alleles provide in-
creased resistance against single pathogens [12–17] or
that heterozygous individuals are better at coping with
particular pathogens, especially when they are chal-
lenged by a mixture of infectious agents [18–23].
It is interesting to note that the correlation between
HLA diversity (corrected for colonization history) and
pathogen richness is detected despite the fact that we
used a very conservative measurement for the selective
pressure induced by pathogen communities (i.e., sim-
ply counting the number of disease agents recorded in
each country irrespective of their burden). Not account-
ing for prevalence translates into some diseases being
present in essentially all populations and thus not hav-
ing any statistical weight. This approach further under-
estimates the true effect of many diseases, such as in-
fluenza or malaria, comprising heterogeneous mixes of
pathogen strains that may have different HLA associa-
tions.
Obviously, an implicit assumption behind our inter-
pretation of these results as supportive for the PDBS
hypothesis is that both current patterns of human ge-
netic diversity and present distribution of pathogens on
Earth reflect the conditions that may have shaped the
evolutionary relation between pathogen richness and
HLA polymorphism in the past. In particular, we assume
(1) that current pathogen richness provides a reliable
picture of the selective landscape experienced by hu-
man populations in the past and (2) that the current
distribution of human genetic diversity has not been af-
fected very much by the recent increase in human mi-
gration.
Numerous countries have recently undergone what is
known as the epidemiological transition (some 300
years ago in some developed countries and less than
80 years ago for underdeveloped countries) [33]. This
transition corresponds to major changes whereby para-
sitic-disease mortality decreased, reducing the selec-
tive pressure imposed on human populations by infec-
tious diseases [33]. However, despite medical progress,
global selective pressure imposed by pathogens is still
very high because infectious diseases continue to be a
major cause of mortality—they are responsible for 48%
of deaths worldwide in people under the age of 45 [34].
Although the relative fitness costs owing to individual
pathogen species have greatly evolved over the last
centuries, with some diseases previously causing ex-
treme mortality now under control and others expand-
ing their range (emerging infectious diseases such as
HIV), it is unlikely that the relative number of pathogens
per country, irrespective of their prevalence, has greatly
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1026changed over recent times. Equally, recent population
admixture linked to an increase of migration is unlikely
to have had major effects on a worldwide scale (at least
for native populations such as those considered in the
present study), as shown by the excellent relationship
between geographic distance to Ethiopia and neutral
genetic diversity [28].
In conclusion, our results add strong support to the
PDBS hypothesis. To date, many studies on HLA have
focused on variation within single populations [16]. Al-
though such an approach has proved very successful
at detecting evidence for natural selection, it is not well
1suited for inferring the nature of the selective agent. In
this paper, we approached the question in a compara-
1
tive manner by contrasting patterns of variation at HLA
genes, the effect of historical migrations, and selection
1pressures across populations. This approach enabled
us to show that while human colonization history has
been important in shaping the present patterns ob-
served at HLA genes, the diversity of pathogens has
also been important in driving and maintaining the ge- 1
netic diversity at HLA genes. We believe that this study
adds an exciting example to the few cases of natural
selection, acting on the human genome, for which the
1underlying selective factors are identified.
Supplemental Data
1
Supplemental Data including a full description of the databases
and methods used and some supplemental results and analyses
are available at http://www.current-biology.com/cgi/content/full/
15/11/1022/DC1/.
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